Key points
- Record Q4 positive operating cashflow of $7.7M
- FY26 positive operating cashflow of $6.8M, up 19%
- Completed acquisition of Kyra flow products from Telstra Health
- Cash balance of $20.6M, no debt as of 30 June 2026
- FY26 revenue expected to be ~$51.6M, EBITDA to exceed $5.0M
Full summary
Alcidion Group Ltd released its Q4 FY26 Quarterly Activities Report, highlighting a record positive operating cashflow of $7.7M for the quarter and $6.8M for the full year, up 19% from FY25. The company also completed the acquisition of Kyra flow products from Telstra Health, adding 31 new customers across ANZ. Alcidion's cash balance stood at $20.6M with no debt as of 30 June 2026. The company reconfirms its FY26 financial guidance with revenue expected to be ~$51.6M and EBITDA to exceed $5.0M. Alcidion enters FY27 with strong momentum and a significant book of implementation revenue.
Guidance
FY26 revenue expected to be ~$51.6M, EBITDA to exceed $5.0M
Outlook
Alcidion enters FY27 with strong momentum across all existing markets and continues to progress several opportunities while maintaining a significant book of implementation revenue.